Impact of palliative care on quality of life in advanced cancer: A meta-analysis of randomised controlled trials

Eur J Cancer Care (Engl). 2022 Nov;31(6):e13647. doi: 10.1111/ecc.13647. Epub 2022 Jul 13.

Abstract

Introduction: This study aimed to examine the impact of palliative care on the life quality of adults with advanced cancer.

Methods: After a comprehensive and regular search using [MeSH] keywords in some important databases, 25 published randomised controlled trials (RCTs) involving 5160 adults with advanced cancer were selected and examined through meta-analysis.

Results: Analysis of 36 reports in 1-3 months follow-up, and 19 reports in 4-7 months follow-up, showed that compared to usual care (g = 0.25; 95%CI: 0.1 to 0.41), palliative care had a significant impact on quality of life (QOL) (g = 0.1; 95%CI: 0.019 to 0.18) of advanced cancer patients. Also, based on the analysis of 15 reports on outpatients (g = 0.27; 95%CI: 0.04 to 0.4), 10 reports of early (g = 0.27; 95%CI: 0.029 to 0.52), and 8 reports of end-of-life (g = 0.24; 95%CI: 0.06 to 0.47) palliative care in 4-7 months follow-up, a significant impact on life quality was shown. However, in four reports, the impact of palliative care on health related quality of life in ≥10 months follow-up (g = 0.19; 95%CI: -0.03 to 0.42) was not significant.

Conclusion: Systematic QOL assessment with valid tool in palliative care setting would establish quality assurance and could further develop the application of this pretty new discipline in oncology care worldwide.

Keywords: cancer; meta-analysis; palliative care; quality of life; randomised controlled trials.

Publication types

  • Meta-Analysis
  • Review

MeSH terms

  • Adult
  • Humans
  • Medical Oncology
  • Neoplasms* / pathology
  • Neoplasms* / therapy
  • Palliative Care*
  • Quality of Life
  • Randomized Controlled Trials as Topic